Association of high γ′ fibrinogen levels with adverse events in patients with COVID-19

Association of high γ′ fibrinogen levels with adverse events in patients with COVID-19

Saved in:

Bibliographic Details
Main Authors:	Queen Revollido, Lydia Buzzard, David X. Lee, Matthew Strnad, Scott McLoud, Akram Khan, William B. Messer, David H. Farrell
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Blood Vessels, Thrombosis & Hemostasis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950327225000051
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fibrinogen: A Marker in Predicting Diabetic Foot Ulcer Severity
by: X. H. Li, et al.
Published: (2016-01-01)

Role of Serum Fibrinogen Levels in Patients with Rotator Cuff Tears
by: Umile Giuseppe Longo, et al.
Published: (2014-01-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
by: Astri Budikayanti, et al.
Published: (2018-01-01)

Mineralization Potential of Electrospun PDO-Hydroxyapatite-Fibrinogen Blended Scaffolds
by: Isaac A. Rodriguez, et al.
Published: (2012-01-01)

Biochemical Analysis of Pentraxin 3 and Fibrinogen Levels in Experimental Periodontitis Model
by: Gonca Cayir Keles, et al.
Published: (2012-01-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

Peripheral Arterial Disease in Type 2 Diabetes Is Associated with an Increase in Fibrinogen Levels
by: Qin-Fen Chen, et al.
Published: (2018-01-01)

The Effect of Reagents Mimicking Oxidative Stress on Fibrinogen Function
by: Jana Štikarová, et al.
Published: (2013-01-01)

Musculoskeletal Adverse Events Associated with PCSK9 Inhibitors: Disproportionality Analysis of the FDA Adverse Event Reporting System
by: Lingqing Ding, et al.
Published: (2022-01-01)

Correlation between Maximum Clot Firmness in FIBTEM and Fibrinogen Level in Critical Trauma Patients
by: Supphamongkhon Khunakanan, et al.
Published: (2019-01-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system
by: Jingrong Yang, et al.
Published: (2025-01-01)

Acknowledging and addressing real-world challenges to treating immune-related adverse events
by: Bonnie L Bermas, et al.
Published: (2024-07-01)

A disproportionality analysis of FDA adverse event reporting system events for misoprostol
by: Li Yang, et al.
Published: (2025-01-01)

A systematic review of machine learning applications in predicting opioid associated adverse events
by: Carlos R. Ramírez Medina, et al.
Published: (2025-01-01)

Neuropsychiatric adverse events associated with Glucagon-like peptide-1 receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database
by: Wenchao Lu, et al.
Published: (2025-01-01)

A post-marketing pharmacovigilance study of triazole antifungals: adverse event data mining and analysis based on the FDA adverse event reporting system database
by: Yalan Tian, et al.
Published: (2025-01-01)

Efficacy and fibrinogen correlations of defibrinogen therapy in idiopathic sudden sensorineural hearing loss
by: Bing Wang, et al.
Published: (2025-02-01)

Aseptic Meningitis as an Immune-Related Adverse Event after Pembrolizumab
by: Gian Lima, et al.
Published: (2019-01-01)

Rates of Minor Adverse Events and Health Resource Utilization Postcolonoscopy
by: Vladimir Marquez Azalgara, et al.
Published: (2014-01-01)

Scanning and vicarious learning from adverse events in health care
Published: (2001-01-01)

Examining vaccination-related adverse events in frequent neurodegenerative diseases
by: Shabnam Sodagari, et al.
Published: (2025-02-01)

Autoimmune pancerebellitis as an immune-related adverse event: an illustrative case
by: D. Valančius, et al.
Published: (2021-12-01)

Investigation of the total anticholinergic load of reported anticholinergic drug-related adverse events using the Japanese adverse drug event report database: a retrospective pharmacovigilance study
by: Yusuke Kan, et al.
Published: (2025-01-01)

Adverse events associated with the delivery of telerehabilitation: A scoping review protocol.
by: Thomas Yau, et al.
Published: (2024-01-01)

Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
by: Yan Xiao, et al.
Published: (2020-01-01)

Analysis of Adverse Events during Intrahospital Transportation of Critically Ill Patients
by: Francielli Mary Pereira Gimenez, et al.
Published: (2017-01-01)

Mania as a Rare Adverse Event Secondary to Steroid Eye Drops
by: Moayyad Alsalem, et al.
Published: (2022-01-01)

Albumin-to-Fibrinogen Ratio Independently Predicts 28-Day Mortality in Patients with Peritonitis-Induced Sepsis
by: Huiyu Tai, et al.
Published: (2020-01-01)

Modulation of Dental Pulp Stem Cell Odontogenesis in a Tunable PEG-Fibrinogen Hydrogel System
by: Qiqi Lu, et al.
Published: (2015-01-01)

Adverse events in the nervous system associated with blinatumomab: a real-world study
by: Wen Gao, et al.
Published: (2025-02-01)

Factors Predicting Adverse Events Associated with Pregabalin Administered for Neuropathic Pain Relief
by: Yuko Kanbayashi, et al.
Published: (2014-01-01)

Impact of discontinuation of cephazolin prophylaxis on the incidence of postoperative adverse events in cataract surgery
by: Kazutaka Uchida, et al.
Published: (2025-01-01)

Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events
by: Tomoko Kobayashi, et al.
Published: (2024-01-01)

Automatic tool for the reconciliation of serious adverse events for pharmacovigilance: design and implementation of Reconciliaid
by: Sara Contu, et al.
Published: (2025-01-01)

Comparisons of adverse events associated with immune checkpoint inhibitors in the treatment of non-small cell lung cancer: a real-world disproportionality analysis based on the FDA adverse event reporting system
by: Ruichen Gao, et al.
Published: (2025-02-01)

Fibrinogen-to-Albumin Ratio Predicts Contrast-Induced Nephropathy in Patients after Emergency Percutaneous Coronary Intervention
by: Zhebin You, et al.
Published: (2019-01-01)

Combining the Fibrinogen/Albumin Ratio and Systemic Inflammation Response Index Predicts Survival in Resectable Gastric Cancer
by: Junbin Zhang, et al.
Published: (2020-01-01)

Development and Validation of the Systemic Inflammatory Response Index-Based Nomogram for Predicting Short-Term Adverse Events in Patients With Acute Uncomplicated Type B Aortic Intramural Hematoma
by: Wang Y, et al.
Published: (2025-01-01)

Expanding on Abraxane Safety: Temporal Insights and Future Directions for Adverse Event Analysis [Letter]
by: Yang F, et al.
Published: (2025-02-01)